FN1 and chronic myelogenous leukemia, BCR-ABL1 positive: As shown in Figure 3, CML or pentosidine at 2–16 μmol/L up-regulated ICAM-1 and fibronectin protein expression in A549 and Calu-6 cells (p < 0.05).